As announced a couple of weeks ago, UICC is in the process of reviewing its long-term strategic options. We would like to thank those who have already participated in UICC’s Membership Survey and UICC Strategy Review process by sharing with us resources that could influence the global cancer control landscape. We highly encourage our members who have not yet participated in UICC’s Membership Survey to take 15 minutes to complete it by Wednesday, May 4. In October 2022, UICC President, Anil D’Cruz, will present the conclusions of that review during the General Assembly.
Please do not hesitate to share your resources with the Membership Team at email@example.com.
Hayley Jones looks back at the McCabe Centre for Law & Cancer’s impact and extends an invitation for everyone to get involved in using the law for cancer prevention and control.
The McCabe Centre’s work built on Cancer Council’s longstanding successes leveraging law and policy to improve cancer outcomes in Australia, and UICC’s expertise uniting and building capacity in the cancer control community around the world.
In May, the World Bladder Cancer Patient Coalition (WBCPC) is inviting cancer advocacy organisations around the world to join in their new campaign. Bladder cancer is the 10th most commonly diagnosed cancer in the world, with over 570,000 patients diagnosed every year. You can help bring much-needed attention to bladder cancer during the Bladder Cancer Awareness Month in May.
This year WBCPC will spark conversations that drive awareness around bladder cancer by honing in on most common symptom – blood in urine, and the problem they bring. The vast majority of things we’re embarrassed about are harmless, these symptoms, however, might not be.
It’s a strong single-minded campaign thought: Don’t feel embarrassed by these symptoms or talking about them. Act on them.
Explore the campaign toolkit to discover the campaign and how you can contribute in your community whether you have a minute or more time to share on Bladder Cancer Awareness Month page.
June 16 is World Kidney Cancer Day. It’s a day when the global kidney cancer community comes together to raise awareness of key issues facing kidney cancer patients and their caregivers around the world.
Studies by the International Kidney Cancer Coalition (IKCC) show that many kidney cancer patients aren’t aware of the treatment options that may be available to them and don’t discuss them with their doctors nearly as often or as thoroughly as they should.
Sometimes it’s because patients don’t feel they know enough or don’t feel they can question their doctors. Other times it’s because doctors don’t want to overwhelm their patients or their appointments are too short.
Talking about treatment options, including access to clinical trials, leads to better treatment outcomes. For example, some 90% of kidney cancer patients say they would seriously consider being part of a clinical trial if they were asked; but fewer than half are ever asked and most have no idea what trials might be available for them. That’s why the theme for the IKCC World Kidney Cancer Day 2022 is ‘We need to talk about treatment options’.
To help create more and better conversations between patients and their cancer care teams, the IKCC has launched a global online campaign, including the six questions every kidney cancer patient should feel able to ask their doctor, which patients can download and take to their next appointment.
On World Kidney Cancer Day itself there will be a landmark global webinar where patients and clinicians will discuss the challenges and opportunities of having better conversations about treatment options and answer questions about how we can do better.
King Hussein Cancer Foundation from Jordan is delighted to share with you the news of the opening of the second cycle of the King Hussein Award for Cancer Research, which was launched in November 2020 by HRH Princess Ghida Talal.
The Award will recognize cancer researchers – both established and promising – from across the Arab world who are contributing to our understanding of cancer, advancing much-needed research in our region, and accelerating life-saving treatment as a result. Award recipients will be honoured in a ceremony in Amman, Jordan in November 2022.
The King Hussein Award consists of four categories, and they highly encourage researchers and young investigators to apply to one or more of the categories in line with the requirements.
Médecins du Monde France is happy to share its pedagogical kit for cervical cancer prevention. The kit provides a summary of current knowledge about cervical cancer prevention and is available both in French and English.
This pedagogical kit helps design and implement programs on Cervical Cancer prevention (P-CC) and precancerous lesion management through a public health approach and the promotion of sexual and reproductive rights.
The kit contains two handbooks, one trainer’s handbook and one participant handbook, which can be used for participatory trainings aimed at adult audiences and can also serve as a resource.
Dr Sonali Johnson, Head of Knowledge, Advocacy and Policy at UICC and Shalini Jayasekar-Zürn, Senior Advocacy Manager at UICC, are two of the co-authors of the article “Multicancer early detection: Accelerating Progress Through International Collaboration”. The paper is one of the seven articles published in a ground-breaking supplement of the journal Cancer on the potential of an MCED strategy.
We are pleased to announce that Cancer Research UK is hosting a webinar on "Future of HPV vaccination in India" with their research partners, RTI International, on Wednesday 25th May 2022 at 09:00 BST / 10:00 CET / 13:30 IST. RTI International will be sharing the findings of their research work, which explored means of introducing of HPV vaccination across India, and launching a policy brief informed by these findings.
Join them to hear a diverse group of national health experts discuss the future of HPV vaccination in India, including challenges that exist to its introduction in the universal immunisation programme of India, potential strategies to overcome these challenges and disseminate the study findings.
As part of the 2022 Global Policy Webinar Series: Understanding the Global Challenges to Equitable, High-Quality Cancer Care, the National Comprehensive Cancer Network (NCCN) is organising a webinar on The Impact of Policy and Regulation on Guideline-Concordant Cancer Care Globally, to be held on June 29, 2022.
The 2022 Global Policy Webinar Series, Understanding the Global Challenges to Equitable, High-Quality Cancer Care, will provide an opportunity for a varied group of global stakeholders including patients, patient advocates, oncology providers, policymakers, and caregivers, to highlight and discuss global challenges to equitable and high-quality cancer care, across the continuum of care, from diverse geographic perspectives. The two sessions will also provide a platform for patients worldwide to discuss inequities in treatment options and care in their country and within their respective health systems.
Prevent Cancer Foundation is excited to return in person from June 9-10 for the 2022 Prevent Cancer Dialogue. The Dialogue will be held at the Renaissance Arlington Capital View Hotel in Arlington, VA!
This year, the Prevent Cancer Dialogue will focus on the theme of advancing health equity through innovation. Attendees will have the opportunity to hear from well-known experts and engaging speakers on important trending topics in cancer prevention and early detection. Register today to be part of valuable conversations with colleagues and leaders in the field.
All.Can International is a global, non-profit and multi-stakeholder initiative launched in 2016 to inform and generate political and public engagement on the need to improve the efficiency of cancer. Its mission is to support policy initiatives to improve cancer care efficiency by generating new evidence and facilitating the exchange of knowledge and best practices.
In February 2022, All.Can launched its “Building Efficiency in Cancer Care” blueprint which explains why achieving greater efficiency must be an urgent policy priority and puts forward a broadly applicable framework aimed at policymakers to help achieve efficiency throughout the cancer care continuum. In June 2022, All.Can will publish its Efficiency Metrics policy research which will propose a set of internationally applicable and real-world measures and aim to harmonise and set standards in cancer care efficiency globally.
Capitalising on the momentum around the landmark EU and international policy initiatives underway on cancer care, and on All.Can’s latest publications, the summit will constitute a unique platform to exchange on ways to implement efficiency in cancer care and will aim to identify concrete, actionable steps to improving cancer care globally.
With the overall mission to identify concrete ways to build and implement efficiency in cancer care globally, the event will give a voice to patients, healthcare professionals, European and national policy-makers and decision-makers, industry players, national associations and initiatives, academics and researchers across the globe around four key themes: empowering & partnering with people, supporting healthcare professionals, implementing a data-driven learning system and investing in efficient technologies.
Access the Global Summit Programme here.
The International Psycho-Oncology Society (IPOS) in partnership with the Canadian Association of Psychosocial Oncology (CAPO) is pleased to announce that registrations for the 2022 IPOS/CAPO Joint World Congress are now open. The Congress will run from August 29 to September 1, with in-person and virtual options.
The shared mission of the Canadian Association of Psychosocial Oncology (CAPO) and the International Psycho-Oncology Society (IPOS) is to foster the science and practice of psychosocial oncology to improve the care for people affected by cancer through partnerships, research, public policy, advocacy and education.
The 2022 World Congress will create an opportunity to bring together an international body of health care professionals. The forum encourages new global partnerships and allows for the dissemination of ground-breaking research to professionals and the general public about psycho-oncology, that is, the psychosocial (psychiatric, psychological, social, behavioural, ethical) and psychobiological aspects of oncology. Finally, it allows to recognize exceptional contributions from around the world to the field of psycho-oncology through the awards of excellence.
On behalf of its Organising Committee, the Asian Oncology Society is very pleased to announce the 2nd International Congress of the Asian Oncology Society (AOS 2022) in conjunction with the 48th Annual Meeting of Korean Cancer Association to be held on June 16-18, 2022 in Seoul, Korea.
The AOS has served as a unified organisation of APFOCC (Asian and Pacific Federation of Organisations for Cancer Research and Control) and ACOS (Asian Clinical Oncology Society) since 2018. Under the theme “New Era of Asian Oncology: Challenge, Cure, Care”, the AOS congress will be a great opportunity for participants to share and learn innovative techniques and results of promising research by cancer experts from all over the globe.
Extended Pre-Registration Deadline: May 20, 2022 (KST)
Asociación Metamorfosis addresses the issue of cancer from an integral perspective through the education of the patient, relatives and friends, as well as the community in general. The aim is to raise awareness about the development of this pathology and the importance of early detection, and support the right to treatments with quality, safety and proven effectiveness to control the disease.
Asociación Metamorfosis has implemented a patient navigation project at the San Juan de Dios Hospital, which aims at creating active participation of patients in support groups. The association also works on a project to put in place virtual assistance for oncology patients. The goal is to create support through public-private institutions, for the benefit of the fight against cancer, based on education.
Pink Africa Foundation was founded in January 2017 and networks globally to sustainably improve the educational, social, and health status of African women and children, especially in under-served communities. Every October, Pink Africa Foundation organises the Calabar Go Pink Day (CGPD). It is the biggest health walk and outreach in the city, bringing together partners from all walks of life, to fight the scourge of breast cancer.
Pink Africa Foundation carries out advocacy programs on radio, TV and social media platforms in regards to cancer. The foundation also carry out awareness programs in schools, religious organisations, educational institutions and outreaches in communities with respect to advocacy awareness and free cancer screening to underserved population.
Pink Africa Foundation recently provided support for cost of surgery for 20 patients in Cross River State. In the last year, they also have provided locally produced post mastectomy bras to over 300 breast cancer survivors in Nigeria.
Médecins du Monde (MdM) is a French medical international humanitarian organisation founded in 1980. Its mandate is to provide medical care to the most vulnerable populations affected by crisis situations, disease, famine, poverty and exclusion, in and outside France. MdM's interventions include the prevention and control of cervical cancer, as part of a comprehensive approach in favor of sexual and reproductive health and rights. They identify cervical cancer as a break in the continuum of care for women and girls, revealing social, health, and gender inequities.
In this perspective, MdM's model combines a public health response with a community-based approach based on human rights, supported by an advocacy strategy to influence the definition of national and international health policies. In West Africa, their projects are implementing several innovations aimed at empowering the people concerned (such as vaginal self-sampling) and strengthening the accessibility and performance of screening and treatment of pre-cancerous lesions (organised screening at community level, introduction of HPV testing, thermocoagulation, etc.).
Malabar Cancer Centre (MCC) is an autonomous institution under the Health and Family Welfare Department of the Government of Kerala in India. MCC is a tertiary cancer centre with facilities for diagnosis, treatment and research in cancer. The Malabar Cancer Centre Department of Community Oncology is involved in different cancer control activities and coordinates them. It conducts cancer awareness trainings, volunteer training programs, tobacco awareness classes and tobacco control activities, as well as early cancer detection camps for NGOs and voluntary organizations to set up early cancer detection clinics in remote rural areas. A tobacco cessation clinic and an anti-tobacco cell function under the department.